[LGND] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -7.93%
YoY- 699.45%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 64,835 41,848 24,808 45,663 33,375 21,619 17,701 24.13%
PBT 15,259 -11,612 -19,871 79,226 12,071 804 7,284 13.10%
Tax 1,536 -4,911 -4,620 11,864 3,645 160 -217,255 -
NP 13,723 -6,701 -15,251 67,362 8,426 644 199,165 -35.94%
Tax Rate -10.07% - - -14.97% -30.20% -19.90% 2,982.63% -
Total Cost 51,112 48,549 40,059 -21,699 24,949 20,975 -181,464 -
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin 21.17 -16.01 -61.48 147.52 25.25 2.98 1,125.16 -48.39%
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS 0.82 -0.42 -0.81 3.19 0.40 0.03 10.01 -34.07%
EPS Diluted 0.80 -0.42 -0.81 2.80 0.36 0.03 9.28 -33.51%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.